What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Macular degeneration, Surgery, Internal medicine, Genetics and Relative risk are her primary areas of study.
The various areas that Johanna M. Seddon examines in her Macular degeneration study include Odds ratio, Maculopathy, Case-control study, Eye disease and Age related.
Her Eye disease study which covers Visual acuity that intersects with Activities of daily living.
Her study on Prospective cohort study is often connected to Ascorbic acid as part of broader study in Surgery.
Her Internal medicine research incorporates themes from Gastroenterology and Oncology.
Johanna M. Seddon has researched Relative risk in several fields, including Lower risk, Vitamin and Physiology.
Her most cited work include:
- Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration (1261 citations)
- Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration (785 citations)
- Seven new loci associated with age-related macular degeneration (606 citations)
What are the main themes of her work throughout her whole career to date?
Johanna M. Seddon spends much of her time researching Macular degeneration, Internal medicine, Age related, Ophthalmology and Surgery.
Her work in Macular degeneration addresses issues such as Odds ratio, which are connected to fields such as Case-control study.
Her research in Internal medicine tackles topics such as Oncology which are related to areas like Hereditary Retinoblastoma and Retinoblastoma.
In her study, Genetic predisposition is inextricably linked to Physiology, which falls within the broad field of Age related.
She studies Surgery, namely Eye disease.
Her Eye disease study also includes fields such as
- Uvea most often made with reference to Radiation therapy,
- Pathology most often made with reference to Melanoma.
She most often published in these fields:
- Macular degeneration (67.41%)
- Internal medicine (33.92%)
- Age related (30.60%)
What were the highlights of her more recent work (between 2013-2021)?
- Macular degeneration (67.41%)
- Age related (30.60%)
- Internal medicine (33.92%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Macular degeneration, Age related, Internal medicine, Ophthalmology and Genetics.
Johanna M. Seddon works in the field of Macular degeneration, namely Drusen.
Her Age related research is multidisciplinary, incorporating elements of Complement factor I, Advanced stage, Genetic risk and Physiology.
The Internal medicine study combines topics in areas such as Hereditary Retinoblastoma and Oncology.
Her research in Ophthalmology intersects with topics in Framingham Risk Score and Retrospective cohort study.
Her work carried out in the field of Allele brings together such families of science as Eye disease, Body mass index and Genotype.
Between 2013 and 2021, her most popular works were:
- Nature and nurture- genes and environment- predict onset and progression of macular degeneration. (106 citations)
- Nature and nurture- genes and environment- predict onset and progression of macular degeneration. (106 citations)
- Histopathological Insights Into Choroidal Vascular Loss in Clinically Documented Cases of Age-Related Macular Degeneration. (102 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Her primary scientific interests are in Macular degeneration, Pathology, Internal medicine, Genetics and Factor H.
Ophthalmology covers Johanna M. Seddon research in Macular degeneration.
Johanna M. Seddon has included themes like Inflammation and Choroidal neovascularization, Retinal in her Pathology study.
Her work on Internal medicine is being expanded to include thematically relevant topics such as Oncology.
Her Factor H course of study focuses on Complement component 3 and Genetic predisposition.
While the research belongs to areas of Prospective cohort study, she spends her time largely on the problem of Survival analysis, intersecting her research to questions surrounding Eye disease, Genotype and Framingham Risk Score.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
